Scleroderma induced by paclitaxel.
Pedersen
Joanna Vitfell
JV
Jensen
Signe
S
Krarup-Hansen
Anders
A
Riis
Lene
L
D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000473:pathology; D017239:Paclitaxel / Q000008:administration & dosage / Q000009:adverse effects*; D010534:Peritoneal Neoplasms / Q000188:drug therapy* / Q000556:secondary; D012594:Scleroderma, Localized / Q000139:chemically induced* / Q000235:genetics; D012737:Sex Factors; D013997:Time Factors
D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel